American Institute for Advanced Investment Management LLP Invests $464,000 in iShares U.S. Pharmaceuticals ETF $IHE

American Institute for Advanced Investment Management LLP acquired a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 5,351 shares of the company’s stock, valued at approximately $464,000.

A number of other large investors have also added to or reduced their stakes in IHE. EFG International AG acquired a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $38,000. Assetmark Inc. raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 203.9% during the fourth quarter. Assetmark Inc. now owns 465 shares of the company’s stock valued at $39,000 after acquiring an additional 312 shares during the last quarter. O Shaughnessy Asset Management LLC raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 35.0% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock valued at $39,000 after acquiring an additional 120 shares during the last quarter. Blueline Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $41,000. Finally, Ameriflex Group Inc. lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% during the third quarter. Ameriflex Group Inc. now owns 582 shares of the company’s stock worth $42,000 after purchasing an additional 291 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Down 1.1%

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $99.01 on Wednesday. iShares U.S. Pharmaceuticals ETF has a twelve month low of $64.94 and a twelve month high of $100.37. The stock has a market cap of $1.07 billion, a price-to-earnings ratio of 17.75 and a beta of 0.50. The company’s fifty day moving average is $90.92 and its 200 day moving average is $88.46.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.